CASP3 gene expression and the role of caspase 3 in the pathogenesis of depressive disorders.

The aim of our study was to evaluate the expression of the CASP3 gene at both mRNA and protein levels in patients with depressive disorders and to determine the impact of caspase 3 in the pathogenesis of depression; METHODS: A total of 290 subjects, including 190 depressed patients and 100 healthy controls, participated in the study. Socio-demographic and clinical data were collected, and the severity of depressive symptoms was assessed using the Hamilton Depression Rating Scale. Venous blood was collected and gene expression was evaluated using RT-PCR and ELISA at the mRNA and protein levels, respectively; RESULTS: The expression of the CASP3 gene was significantly lower in depressed patients compared to healthy controls at both the mRNA and protein levels. Additionally, a positive correlation was observed between CASP3 gene expression and disease duration as well as the number of depressive episodes; CONCLUSIONS: Further studies are needed to investigate the role of caspase 3 in depressive disorders. © 2023. BioMed Central Ltd., part of Springer Nature.

Citation

Katarzyna Bliźniewska-Kowalska, Piotr Gałecki, Janusz Szemraj, Kuan-Pin Su, Jane Pei-Chen Chang, Małgorzata Gałecka. CASP3 gene expression and the role of caspase 3 in the pathogenesis of depressive disorders. BMC psychiatry. 2023 Sep 06;23(1):656

Mesh Tags

Substances

PMID: 37674109

search → result